The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

The 2025 "American Idol" champion stops by "GMA" to perform his new single, “Heal,” and reflect on his path to victory. A new Trump administration vaccine policy will limit access to COVID-19 shots.

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...